Goldman Sachs Initiates Coverage On Enhabit with Neutral Rating, Announces Price Target of $15
Goldman Sachs analyst Jamie Perse initiates coverage on Enhabit (NYSE:EHAB) with a Neutral rating and announces Price Target of $15.
BofA Is Double-Upgrading Solar Stock FTC Despite ‘Ever-Worsening Macro Backdrop’
Despite a tough macroeconomic backdrop, analysts at BofA Securities expect FTC Solar Inc.'s (NASDAQ: FTCI) volumes and margins to rebound in the coming years as industry-wide solar panel supply improves and delayed projects are completed.
SentinelOne Impresses Analysts With Q4 Beat; Flag Conservative Guidance
Needham analyst Alex Henderson reiterates SentinelOne Inc (NYSE: S)
MKS Instruments Analyst Cuts Estimates And Price Target To Reflect Ransomware Impact
Benchmark analyst Mark Miller maintains MKS Instruments Inc (NASDAQ:MKSI) with a Buy and lowers the price target from $125 to $115. Miller…
SentinelOne Stock Is In The Spotlight Today: What’s Going On?
Shares of cybersecurity firm SentinelOne Inc (NYSE: S) are rising Wednesday after the company reported better-than-expected financial results.
These Analysts Slash Price Targets On SentinelOne Following Weak Revenue Forecast
SentinelOne, Inc. (NYSE: S) reported a narrower-than-expected loss for its fourth quarter. The company, however, but issued full-year revenue guidance below analyst estimates.
Jefferies Initiates Coverage On Vitesse Energy with Buy Rating, Announces Price Target of $23
Jefferies analyst Lloyd Byrne initiates coverage on Vitesse Energy (NYSE:VTS) with a Buy rating and announces Price Target of $23.
TD Cowen Downgrades Oak Street Health to Market Perform, Raises Price Target to $39
TD Cowen analyst Gary Taylor downgrades Oak Street Health (NYSE:OSH) from Outperform to Market Perform and raises the price target from $34 to $39.
SVB Leerink Downgrades Decibel Therapeutics to Market Perform, Lowers Price Target to $2
SVB Leerink analyst Mani Foroohar downgrades Decibel Therapeutics (NASDAQ:DBTX) from Outperform to Market Perform and lowers the price target from $7 to $2.
Compass Point Downgrades Acushnet Hldgs to Neutral, Lowers Price Target to $55
Compass Point analyst Casey Alexander downgrades Acushnet Hldgs (NYSE:GOLF) from Buy to Neutral and lowers the price target from $65 to $55.